Lyophilisation has snow-balled over the years to create a massive number of techniques and technologies that increase the efficiency, stability and cost-effectiveness of the lyophilisation process, and every year brings new technologies and new techniques to combat the issues with the industry and enhance our existing solutions

SMi is proud to present their inaugural conference on Lyophilisation: Freeze-drying in pharmaceuticals & Biopharmaceuticals, with key talks from Medimmune, GSK Biologicals, National Institute for Biological Standards & Control and Roche on the best practices, novel discoveries and industry innovations that are essential to the development of a company’s lyophilisation process. This conference is not to be missed as this is the forum for you to learn, explore and discover the cutting edge areas of the industry, and the essential ways a company can improve its freeze drying methods.

Benefits of attending include

• Learn of formulation techniques that assist in the lyophilisation process, and how to apply these to your own technical issues

• Explore the latest research and development in the industry, and how these have led to improved lyophilisation cycles, both pre, and post up-scaling

• Discover the potential technical and logistical difficulties encountered in all levels of the lyophilisation process

• Consider the regulations in chemical engineering and how compliance can be achieved

• Examine previous examples of up-scaling in the industry, and how to apply these to your own freeze-drying process

• Hear about regulations, monitoring and risk reduction, to improve the cost effectiveness of the cycle, and how these can be used to manage risks and adapt to the problems encountered

Key speakers include

• Yves Mayeresse, Director of Manufacturing, GSK Biologicals

• Sajal Patel, Scientist II, MedImmune

• Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim

• Paul Matejtschuk, Principal Scientist, National Institute For Biological Standards & Control

• Sune Klint Andersen, Principal Scientist Drying Processes, Novo Nordisk A/s

• Jean René Authelin, Global Head of Pharmaceutical Engineering, Pharmaceutical Sciences, Sanofi R&D

• Ahmad Abdul-Fattah, Group Leader, Late Stage Pharmaceutical and Processing Development, Roche

For further information click here